Tao Shi

9PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 28, 2026
Myeloid cell reprogramming combined with zoledronic acid effectively suppresses bone metastasis.

|Jul 15, 2025
Human myelocyte and metamyelocyte-stage neutrophils suppress tumor immunity and promote cancer progression.

Wei Liu, Tao Shi, Chun Lu

|Aug 20, 2024
Immunotherapies targeting the oncogenic fusion gene CLDN18-ARHGAP in gastric cancer.

Yue Wang, Hanbing Wang, Tao Shi

|Jan 18, 2024
Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer.

Keying Che, Yuting Luo, Xueru Song

|Oct 07, 2022
DKK1 Promotes Tumor Immune Evasion and Impedes Anti-PD-1 Treatment by Inducing Immunosuppressive Macrophages in Gastric Cancer.

Tao Shi, Yipeng Zhang, Yue Wang

|Aug 27, 2019
Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population-based study.

Tao Shi, Xueru Song, Qin Liu

Pageof 2

Frequent Collaborators

6 joint publications

Jia Wei

3 joint publications

Keying Che

1 joint publications

Zengjie Lei

1 joint publications

Yipeng Zhang